NCT04817397View on ClinicalTrials.gov

The Lymphocyte/Neutrophil Ratio as a Prognostic Index for Short Term Outcome in the ICU Admitted COVID-19 Adult Patients

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 20, 2021

Primary Completion Date

July 30, 2021

Study Completion Date

August 30, 2021

Conditions
Covid19
Trial Locations (1)

Unknown

Assuit University, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT04817397 - The Lymphocyte/Neutrophil Ratio as a Prognostic Index for Short Term Outcome in the ICU Admitted COVID-19 Adult Patients | Biotech Hunter | Biotech Hunter